Abstract: A dimensionally stable floor covering comprises a tufted textile substrate and a reinforcement layer attached to the textile substrate. The reinforcement layer includes an adhesive backing compound and reinforcement fibers surrounded by the adhesive backing. The fibers may form a continuous layer on the back side of the floor covering or may be dispersed within the adhesive backing compound. The adhesive backing compound may be hot water-soluble to facilitate recycling of the floor covering. The floor covering may optionally include additional backing layers (including cushions) and may be used as a broadloom carpet, a carpet tile, or other modular floor covering products. Methods of manufacturing, installing, and recycling the present floor coverings are also provided.
Abstract: The present invention concerns VLPT immunoreactive compositions for E. chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. chaffeensis VLPT are disclosed.
Abstract: Photoluminescence from a sample detector is detected using an array of photo-sensitive detectors. At least one first photo-sensitive detector of the array is provided with a first type of linear polarization filter and at least one second photo-sensitive detector is provided with a second type of linear polarization filter. The first type of linear polarization filter has a plane of polarization which is at angled with respect to a plane of polarization of said second type of polarization filter.
Abstract: The present invention relates to an air nozzle device (10) for a vehicle (1) comprising a housing (11) defining an interior volume and having an air inlet (12) at one side, an air discharge opening (14) at a second side and an air flow channel (18) through the housing (11) for transporting a flow of air between the air inlet and the air discharge opening, the device (10) further comprising a moveable operating member (30), a shutoff mechanism (40) and an air flow adjustment arrangement (20), said shutoff mechanism (40) being pivotably connected to said housing and configured to regulate the air flow and said air flow adjustment arrangement (20) being pivotably connected to said housing and configured to adjust the direction of the air flow in a longitudinal direction X and in a vertical direction Z, wherein said operating member (30) comprising a user-actuated manual mechanism (32), a first linkage member (34) and a second linkage member (36), wherein said user-actuated manual mechanism (32) is arranged downs
Type:
Grant
Filed:
October 4, 2016
Date of Patent:
March 20, 2018
Assignee:
Ningbo Geely Automobile Research & Development Co., Ltd
Abstract: A particle production apparatus including a generating device, a conveying device, and a straightening device is provided. The generating device includes a tank filled with a dense medium, an electric power source, a first and a second electrical conducting element received in the dense medium and coupled to an anode and a cathode of the electric power source respectively. The conveying device is configured to convey a metal wire into the tank and make the metal wire to contact the first electrical conducting element and the second electrical conducting element in a straight-line direction, so as to produce an electric explosion to form a plurality of particles in the dense medium.
Type:
Grant
Filed:
November 30, 2015
Date of Patent:
March 13, 2018
Assignee:
Metal Industries Research & Development Centre
Abstract: Aqueous compositions suitable for topical administration to the human or animal eye contain at least one water-soluble polymeric ophthalmic lubricant, such as hyaluronate, carbomer gel or hypromellose, together with a water-soluble analgesic. The analgesic may be an opiod, particularly an opioid having an affinity for 5-HT receptors, such as tramadol. The aqueous compositions may for example be used as artificial tears, and as general ophthalmic lubricants for treating conditions such as dry eye or blepharitis. Further compositions combine ophthalmologicallyactive agents, such as pharmaceuticals, with opioids, such as tramadol in particular. These compositions may be used to treat the eye while reducing pain or discomfort that would normally be produced by administering these particular pharmaceuticals to the eye, and increasing the efficacy of the pharmaceuticals.
Type:
Grant
Filed:
March 21, 2016
Date of Patent:
March 13, 2018
Assignee:
Optosolve Research & Development Limited
Abstract: Provided is a self-processing synthesis of hybrid nanostructures, novel nanostructures and uses thereof in the construction of electronic and optoelectronic devices.
Type:
Application
Filed:
April 21, 2016
Publication date:
March 8, 2018
Applicant:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Inventors:
Roie YERUSHALMI, Yossef PALTIEL, Ori PINCHAS-HAZUT, Sharon WAICHMAN, Amir ZIV, Shira YOCHELIS
Abstract: A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
Type:
Application
Filed:
November 20, 2017
Publication date:
March 8, 2018
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Timor BAASOV, Tamar BEN-YOSEF, Igor NUDELMAN, Annie REBIBO-SABBAH, Dalia SHALLOM-SHEZIFI, Mariana HAINRICHSON
Abstract: A method of expanding and maintaining human embryonic stem cells (ESCs) in an undifferentiated state by culturing the ESCs in a suspension culture under culturing conditions devoid of substrate adherence is provided. Also provided are a method of deriving ESC lines in the suspension culture and methods of generating lineage-specific cells from ESCs which were expanded in the suspension culture of the present invention.
Type:
Application
Filed:
November 16, 2017
Publication date:
March 8, 2018
Applicant:
Technion Research & Development Foundation Limited
Abstract: A method of treating or preventing an ovary-related syndrome associated with infertility in a subject in need thereof is provided. The method comprising administering to the subject a pharmaceutical composition comprising an active ingredient consisting of pigment epithelium-derived factor (PEDF) and a pharmaceutically acceptable carrier, thereby treating or preventing the ovary-related syndrome associated with infertility in the subject.
Type:
Grant
Filed:
February 23, 2015
Date of Patent:
February 27, 2018
Assignees:
Ramot at Tel-Aviv University Ltd., The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center
Inventors:
Ruth Shalgi, Dana Chuderland, Ido Ben-Ami, Raphael Ronel
Abstract: A method for managing communication among a plurality of social network members. The method comprises defining a multi participant task, setting at least one forward rule limiting the distribution an invitation message for participating in the multi participant task, forwarding the invitation message to at least one addressee from a plurality of social network members, allowing the at least one addressee to forward the invitation message to at least one additional addressee from the plurality of social network members under the at least one forward rule, monitoring a plurality of feedbacks to the invitation message to determine whether the multi participant task is achieved, and updating a status of the multi participant task according to the determination.
Type:
Grant
Filed:
March 29, 2016
Date of Patent:
February 27, 2018
Assignee:
Technion Research & Development Foundation Limited
Abstract: A hybrid analog-digital pixel circuit is fabricated on two wafers. A first wafer includes the analog pixel circuitry and a second wafer includes the digital control and processing circuitry. Externally accessible contact structures for electrically interconnecting the two wafers are arranged in groups. Each group includes externally accessible contact structures for carrying signals associated solely with operation of a corresponding pixel.
Abstract: Provided are modified lipid compounds and their use in the formation of lipid assemblies. Also provided are lipid assemblies including (a) an amphoteric lipid including in covalent association with (i) one or more acyl chains; (ii) one or more weak base moiety; (iii) one or more weak acid moiety; the lipid assembly also including (b) one or more additional lipids, at least one of which being a zwitterionic lipid. In some embodiments, the amphoteric lipid is a compound including (a) a tri-functional moiety; (b) two non-phosphate lipid chains associated with two of the functional moieties of said tri-functional moiety; (c) optionally a spacer moiety associated with the third of the functional moieties of said tri-functional moiety; and (d) a polyalkylamine optionally including a short peptide with one to several carboxylic acid residues. Further provided are the uses of the lipid assembly, inter alia, for transfection or cancer treatment.
Type:
Application
Filed:
February 4, 2016
Publication date:
February 15, 2018
Applicants:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., QBI Enterprises Ltd., Rosetta Genomics, Biolab Ltd.
Abstract: A method for reducing disk read rate by managing dataset mapping of virtual machine (VM) guest memory, comprising: monitoring a plurality of disk read write operations of a VM guest; updating a dataset mapping between disk blocks allocated to the VM guest and corresponding physical addresses of memory pages of the VM guest containing replica of data stored in the disk blocks, based on the plurality of disk read write operations; when identifying writing to one of the memory pages, removing a mapping of corresponding disk block and corresponding physical address of memory page; when reclaiming a mapped memory page of the VM guest by a host of the VM guest, discarding data contained in the memory page; and when the data is requested by the VM guest after it was reclaimed by said host, retrieving the data from corresponding disk block according to the mapping.
Type:
Application
Filed:
October 3, 2017
Publication date:
February 15, 2018
Applicant:
Technion Research & Development Foundation Limited
Inventors:
Assaf SCHUSTER, Nadav AMIT, Dan TSAFRIR
Abstract: An optical measurement system including a two-dimensional sine wave annuls grating and a measurement unit is provided. The two-dimensional sine wave annuls grating includes a rotary shaft and a plurality of sine wave structures surrounding the rotary shaft and continuously arranged. The measurement unit is adapted to output a light beam towards the two-dimensional sine wave annuls grating, wherein each of the sine wave structures is adapted to reflect the light beam from the two-dimensional sine wave annuls grating back to the measurement unit. A measurement method for errors of a rotating platform and a two-dimensional sine wave annuls grating are also provided.
Type:
Grant
Filed:
December 7, 2015
Date of Patent:
February 13, 2018
Assignee:
Metal Industries Research & Development Centre
Abstract: Expandable vertebral body implants, systems, instruments, and methods of assembly and using the implants, systems, and instruments are disclosed. The vertebral body implant includes a body with a first end and a second end, a first rotating member rotatably coupled to the first end, wherein an end includes a plurality of first notches inset into the first rotating member, a second rotating member rotatably coupled to the second end, wherein an end includes a plurality of second notches inset into the second rotating member, a first extension member moveably coupled to the first end, and a second extension member moveably coupled to the second end. The expandable cage system comprises a vertebral body implant and an insertion instrument. Methods for assembling and using the vertebral body implants and instruments are also disclosed.
Type:
Grant
Filed:
April 13, 2017
Date of Patent:
February 13, 2018
Assignee:
MUSC Foundation for Research Development
Inventors:
Mark Evald Semler, Bruce Frankel, Joseph Ruscito
Abstract: Synthetic peptides containing chemical modifications having anti-tumor properties are provided. Further provided are pharmaceutical compositions including the peptides and use thereof for treating proliferative and neoplastic diseases such as cancer.
Type:
Application
Filed:
February 7, 2016
Publication date:
February 8, 2018
Applicant:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Abstract: An abrasive grain made from melted spherical corundum where the abrasive grain consists of a spherical corundum core, coated with an encircling layer of a binder and fine-grained abrasive solid particles.
Type:
Grant
Filed:
April 25, 2007
Date of Patent:
February 6, 2018
Assignee:
Center for Abrasives and Refractories Research & Development C.A.R.R.D. GmbH
Abstract: Compositions and methods for treating diseases or disorders associated with the metabolic syndrome using conjugates of bile acids with basic amino acids or a decarboxylated amino acid such as agmatine are provided. Further provided are bile acid-basic amino acid conjugates including chenodeoxycholic acid with an amino acid selected from arginine, lysine, histidine, ornithine or a decarboxylated amino acid such as agmatine.
Type:
Grant
Filed:
June 5, 2014
Date of Patent:
February 6, 2018
Assignee:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Inventors:
Oren Tirosh, Ira Voloshin, Shlomo Sasson, Michal Obercyger, Zecharia Madar
Abstract: Semaphorin 3A and uses thereof for treatment of IBD are provided. Further provided is assessing IBD severity or treatment efficacy, including determining Semaphorin 3A levels in a biological sample of a subject afflicted with IBD.
Type:
Application
Filed:
February 9, 2016
Publication date:
February 1, 2018
Applicant:
Medical Research & Development Fund for Health Services Bnai Zion Medical Center